In the wake of a significant recall of applesauce pouches, renewed attention has been drawn to the U.S. Food and Drug Administration’s (FDA’s) food contamination regulatory powers – or the lack thereof. In late October 2023, the FDA issued a safety …
In the UK — England and Wales specifically — October 2023 saw new changes being implemented. In terms of litigation, fixed recoverable cost extensions will cause ripples, and the series of shifts have real potential to upend the market. …
As part of a continued focus on sustainability, the European Commission, Council, and Parliament reached a provisional agreement on the Ecodesign for Sustainable Products Regulation (ESPR) in early December 2023. The new regulation will build on the …
Sedgwick’s industry experts and thought leaders are committed to keeping our clients informed on emerging challenges, opportunities and industry news. We’re excited to introduce our Connect 2024 list, which highlights major industry trends and issues…
With steadily increasing demand for electric vehicle (EV) — the International Energy Agency expects 14 million sales by year’s end of 2023, a 35% year-over-year increase — the speed at which the industry is required to deliver EV sales wi…
Insurance plays a critical role in our society and economy by providing protection against risk and uncertainty. Every day, the insurance industry makes people whole again after something unexpected occurs. Regrettably, there are a few bad actors who…
As we wrap up 2023, we’re presented with an opportunity to reflect on the new and unexpected challenges our clients faced this year — and their resilience along the way. Employers, risk management and human resource professionals, brokers and c…
As our world becomes more data-driven, safeguarding data and privacy has become a growing focus for businesses and the regulatory agencies that set industry standards. Last year, Gartner forecasted that by the end of 2024, 75% of the world’s populati…
U.S. product recalls fell more than 10% in the third quarter of 2023, the largest quarterly decline recorded in over three years according to Sedgwick’s latest Recall Index report. Despite this decrease, 2023 still remains on track to hit a five-year…
The number of European product recalls increased in the third quarter of 2023 for the fifth consecutive quarter, according to Sedgwick’s latest European Recall Index report. Across the five industries tracked in the report, there were 3,227 recalls i…
Regulators, lawmakers and technology experts alike seem to agree on two things: artificial intelligence (AI) is an important piece of our future and it needs guidelines for its use. Across the globe, there has been a recent flurry of activity ranging…
After largely pausing onsite facility inspections during the COVID-19 pandemic, the U.S. Food and Drug Administration (FDA) has resumed this type of oversight in the past 18 months. However, several recent in-market events involving contaminated eye …
Frustration with the EU Medical Devices Regulation (MDR) and In Vitro Diagnostics Regulation (IVDR) continues to mount among industry stakeholders over a lack of quick and economical regulatory approval processes. Since the inaction has resulted in s…
Responding to stakeholder concerns, the U.S. Food and Drug Administration (FDA) announced that it will establish a one-year stabilization period for the Drug Supply Chain Security Act (DSCSA) traceability requirements to ensure continuity of the supp…
The U.S. Food and Drug Administration (FDA) continues to work through the redesign of its organizational structure into one unified Human Foods Program (HFP) and recently highlighted its dietary supplements program as a critical priority. In an upd…